LOIS: Long-Term Follow-Up in INSITE/SIFI
Public ClinicalTrials.gov record NCT02270203. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the long term safety and effectiveness of SI joint fusion using the iFuse Implant System in patients with degenerative sacroiliitis (DS) and/or sacroiliac joint disruptions (SD). Study Design: This study is extended follow-up from two ongoing multicenter prospective US clinical trials. All participants have already undergone the surgical procedure of interest (SI joint fusion with iFuse Implant System). The two ongoing trials are: * SIFI:( Sacroiliac Joint Fusion with iFuse Implant System) a single-arm trial of patients with degenerative sacroiliitis or sacroiliac joint disruption who underwent iFuse placement, and * INSITE(Investigation of Sacroiliac Fusion Treatment): a randomized clinical trial of the same patient population who underwent either non-surgical treatment or iFuse placement
Study identification
- NCT ID
- NCT02270203
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 103 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 21 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2014 (Type not available)
- Primary completion
- Jul 2019 (Actual)
- Completion
- Jul 2019 (Actual)
- Last update posted
- Aug 6, 2019
2014 – 2019
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yale University School of Medicine | New Haven | Connecticut | 06510 | — |
| Regenerative Orthopaedics and Spine Institute | Stockbridge | Georgia | 30281 | — |
| Orthopaedic Center of Southern Illinois | Mount Vernon | Illinois | 62864 | — |
| Bluegrass Orthopaedics & Hand Care | Lexington | Kentucky | 40509 | — |
| Columbia Orthopaedic Group | Columbia | Missouri | 65201 | — |
| Oklahoma Center for Spine & Pain Solutions | Oklahoma City | Oklahoma | 73159 | — |
| Allegheny Medical Center | Pittsburgh | Pennsylvania | 15212 | — |
| MUSC | Charleston | South Carolina | 29425 | — |
| Precision Spine Care | Tyler | Texas | 75701 | — |
| Overlake Hospital Medical Center | Bellevue | Washington | 98004 | — |
| Aurora Research Institute | Green Bay | Wisconsin | 54311 | — |
| Integrated Spine Care | Wauwatosa | Wisconsin | 53132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02270203, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02270203 live on ClinicalTrials.gov.